Table 4.
Features | p-Value | 5-Year Survival Rate (95% CI) |
---|---|---|
Gender | 0.32 | |
Men | 73.3 (63.05–81.47) | |
Women | 79.6 (69.36–87.07) | |
Age | 0.0066 | |
≤70 years | 80.3 (71.99–86.65) | |
>70 years | 67.9 (54.52–78.91) | |
Histological type | 0.026 | |
Carcinoid | 78.2 (70.11–84.57) | |
Adenocarcinoma | 68.2 (47.32–83.64) | |
Epidermoid carcinoma | 91.7 (64.61–98.51) | |
Others | 42.9 (15.82–74.95) | |
Mean tumoral diameter | 0.057 | |
≤3 cm | 80.3 (72.15–86.49) | |
>3 cm | 66.9 (52.77–78.54) | |
Pleural invasion (P) | 0.0026 | |
0 | 78.6 (69.9–85.32) | |
1 | 84.8 (69.08–93.35) | |
2 | 61.1 (38.62–79.7) | |
3 | 33.3 (9.68–70) | |
TNM Stage | 0.049 | |
T1 | 84.3 (75.02–90.61) | |
T2 | 72.7 (59.77–82.72) | |
T3 | 59.1 (38.73–76.74) | |
T4 | 66.7 (30–90.32) | |
N0 | 0.000079 | 83.1 (75.9–88.46) |
N1 | 46.2 (23.21–70.86) | |
N2 | 46.3 (25.35–68.69) | |
Lung cancer stage | 0.00015 | |
I | 86.7 (78.86–91.89) | |
II | 63.4 (48.12–76.41) | |
III | 50 (29.93–70.07) | |
BMI: (kg/m2) | 0.60 | |
≤25 | 77.6 (67.56–85.17) | |
>25 | 75 (64.52–83.19) | |
ASA | 0.9 | |
1 | 80 (54.81–92.95) | |
2 | 76.1 (68.4–82.34) | |
3 | 75 (40.93–92.85) | |
Resection type | 0.52 | |
Segmentectomy | 72.2 (56.01–84.15) | |
Lobectomy | 77.5 (69.56–83.87) | |
Chronic obstructive pulmonary disease | 0.061 | |
No | 77.3 (68.47–84.29) | |
Yes | 74.6 (62.2–83.94) | |
High blood pressure | 0.36 | |
No | 78.8 (69.23–86.02) | |
Yes | 73.3 (62.37–82.02) | |
Coronary artery disease | 0.53 | |
No | 77 (69.55–83.05) | |
Yes | 70.6 (46.87–86.72) | |
Lower limb atheroma | 0.27 | |
No | 75.1 (67.59–81.40) | |
Yes | 87.5 (63.98–96.5) | |
Atrial fibrillation | 0.96 | |
No | 76.3 (68.98–82.27) | |
Yes | 77.8 (45.26–93.68) | |
Diabetes | 0.12 | |
No | 78.1 (70.58–84.14) | |
Yes | 65.2 (44.89–81.19) | |
Neoadjuvant treatment | 0.26 | |
No | 77.2 (69.98–83.17) | |
Yes | 63.6 (35.38–84.83) | |
Smoking | ||
Never | 0.43 | 80.8 (63.74–90.98) |
Former | 72.7 (62.55–80.90) | |
Current | 80 8 (66.18–89.10) |